Fed. Circ.'s Approach To Unexpected Results In Pharma Cases
There have been many obviousness challenges to pharmaceutical patents since the generic industry began contesting the validity of patents protecting brand company products under the Hatch-Waxman framework. In many, patentees have...To view the full article, register now.
Already a subscriber? Click here to view full article